SANKAR NAVANEETHAN to Naphthyridines
This is a "connection" page, showing publications SANKAR NAVANEETHAN has written about Naphthyridines.
Connection Strength
0.280
-
First interim results from FINE-REAL: a prospective, non-interventional, phase 4 study providing insights into the use and safety of finerenone in a routine clinical setting. J Nephrol. 2024 Nov; 37(8):2223-2232.
Score: 0.235
-
Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease. Cochrane Database Syst Rev. 2020 10 27; 10:CD007004.
Score: 0.045